CrowdStrike Charlotte AI vs Komodo Health AI
A direct comparison using the real catalog fields currently available for both products.
Last updated
CrowdStrike Charlotte AI
CrowdStrike
Komodo Health AI
Komodo Health
Enterprise pricing bundled with CrowdStrike Falcon platform. Included in Falcon Flex subscription.
Enterprise licensing to pharmaceutical companies, health systems, and payers. No public pricing. Contact for pricing.
CrowdStrike Falcon platform (all modules)
CrowdStrike enterprise security. SOC 2 Type II. ISO 27001. FedRAMP authorised. Customer security data processed within Falcon's secure environment.
HIPAA compliant with BAA. SOC 2 Type II. IRB approval for research datasets. De-identification standards. Enterprise data handling agreements.
Security telemetry processed within CrowdStrike's Falcon platform boundary.
Patient health data de-identified under HIPAA de-identification standards. Access requires data use agreements and IRB approval for research purposes. Review Komodo's data governance framework.
- Embedded in market-leading EDR platform without additional tool adoption
- Grounded in CrowdStrike's proprietary threat intelligence from OverWatch
- Natural language reduces technical barrier for less experienced analysts
- Included in Falcon Flex pricing for enterprise subscribers
- 330 million patient longitudinal data coverage is one of the most comprehensive US real-world health datasets
- Integrated claims, lab, and EHR data provides richer patient journey evidence than single-source datasets
- Pulse SaaS interface makes real-world evidence accessible without custom database development
- Pharmaceutical market access teams can generate regulatory-grade evidence from real-world data
- Primarily useful for existing CrowdStrike customers
- Less vendor-agnostic than Microsoft Security Copilot
- Enterprise-only licensing appropriate for pharmaceutical companies and large health systems with analytics budgets
- Real-world data has limitations — claims-based patient identification is less accurate than clinical data
- Regulatory acceptance of real-world evidence varies by market and indication — not a substitute for clinical trials
Advertisement
CrowdStrike Charlotte AI best for
Komodo Health AI best for
Advertisement